Report: Spain Diabetes Care Devices Market Analysis and Forecasts to 2015 TOC

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Executive Summary 11
4 Definitions of Markets Covered in the Report 12
4.1 Diabetes Care Devices 12
4.2 Glucose Monitoring Devices 12
4.2.1 Blood Glucose Meters 12
4.2.2 Blood Glucose Strips 12
4.3 Insulin Delivery 12
4.3.1 Insulin Pens 12
4.3.2 Insulin Syringes 13
4.3.3 Insulin Pumps 13
4.3.4 Traditional Insulin Pump Accessories 13
5 Healthcare Sector Review 14
5.1 Healthcare Expenditure 14
5.2 Healthcare Infrastructure 15
5.3 Healthcare Policy 19
6 Regulation System 21
6.1 Medical Equipment Approval Process 21
6.1.1 Classification of medical devices 21
6.1.2 Conformity Assessment Process 30
6.2 Post Market Surveillance (PMS) 33
7 Pricing and Reimbursement 34
7.1 Pricing and Reimbursement Policies 34
8 Distribution Structure 35
9 Diabetes Care Devices In Spain 36
9.1 Diabetes Care Devices, Spain, Overall Revenue ($m), 2000-2015 36
9.2 Diabetes Care Devices, Spain, Category Volume (Units), 2000-2015 40
9.3 Diabetes Care Devices, Spain, Cross-Category Analysis, 2000-2015 43
9.4 Diabetes Care Devices, Spain, Company Share (2007-2008) 44
10 Glucose Monitoring In Spain 45
10.1 Glucose Monitoring Overall Revenue (2000-2015) 45
10.1.1 Blood Glucose Meters Overall Revenue (2000-2015) 48
10.2 Glucose Monitoring Overall Volume (2000-2015) 50
10.2.1 Blood Glucose Meters Overall Volume (2000-2015) 52
10.3 Glucose Monitoring, Spain, Cross-Segment Analysis, 2000-2015 53
10.4 Glucose Monitoring Average Price (2000-2015) 54
10.5 Glucose Monitoring Market Dynamics 55
10.5.1 Market Drivers 55
10.5.2 Market Restraints 55
10.6 Glucose Monitoring Distribution Share (2007-2008) 56
10.7 Glucose Monitoring, Spain, Company Share (2007-2008) 57
11 Insulin Delivery In Spain 58
11.1 Insulin Delivery Overall Revenue (2000-2015) 58
11.1.1 Insulin Pens Overall Revenue (2000-2015) 62
11.2 Insulin Delivery Overall Volume (2000-2015) 64
11.2.1 Insulin Pens Overall Volume (2000-2015) 66
11.3 Insulin Delivery, Spain, Cross-Segment Analysis, 2000-2015 68
11.4 Insulin Delivery Average Price (2000-2015) 69
11.5 Insulin Delivery Market Dynamics 70
11.6 Insulin Delivery Distribution Share (2007-2008) 71
11.7 Insulin Delivery, Spain, Company Share (2007-2008) 72
12 Overview of Key Companies in Spain Diabetes Care Devices Market 73
12.1 F. Hoffmann-La Roche Ltd. 73
12.1.1 Company Overview 73
12.1.2 Value Chain Analysis 74
12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 76
12.2 LifeScan, Inc. 77
12.2.1 Company Overview 77
12.2.2 LifeScan, Inc. Pipeline Products 77
12.3 Bayer HealthCare AG 79
12.3.1 Company Overview 79
12.3.2 Value Chain Analysis 79
12.3.3 Bayer HealthCare AG Pipeline Products 81
12.4 Abbott Laboratories 83
12.4.1 Company Overview 83
12.4.2 Value Chain Analysis 83
12.4.3 Abbott Laboratories Pipeline Products 85
12.5 Becton, Dickinson and Company 88
12.5.1 Company Overview 88
12.5.2 Value Chain Analysis 88
12.6 Novo Nordisk A/S 90
12.6.1 Company Overview 90
12.6.2 Novo Nordisk A/S Pipeline Products 90
12.7 Eli Lilly and Company 92
12.7.1 Company Overview 92
12.7.2 Value Chain Analysis 92
12.7.3 Eli Lilly and Company Pipeline Products 94
12.8 Medtronic, Inc. 96
12.8.1 Company Overview 96
12.8.2 Value Chain Analysis 97
12.8.3 Medtronic, Inc. Pipeline Products 99
12.9 ARKRAY, Inc. 107
12.9.1 Company Overview 107
12.9.2 ARKRAY, Inc. Pipeline Products 107
12.10 Terumo Corporation 108
12.10.1 Company Overview 108
12.10.2 Value Chain Analysis 108
12.11 Animas Corporation 110
12.11.1 Company Overview 110
12.12 Sanofi-Aventis 111
12.12.1 Company Overview 111
12.13 Smiths Medical 111
12.13.1 Company Overview 111
12.13.2 Value Chain Analysis 112
13 APPENDIX 114
13.1 GlobalData Research Methodology 114
13.2 Coverage 115
13.3 Secondary Research 116
13.4 Primary Research 116
13.5 Models 117
13.6 Forecasts 117
13.7 Expert Panel Validation 118
13.8 Currency Conversion 119
13.9 Contact Us 120
13.10 Disclaimer 120

1.1 List of Tables
Table 1: Number of Doctors by Specialty in Spain, 2003-2007 16
Table 2: Number of Hospital Wards by Specialty in Spain, 2003-2007 17
Table 3: Healthcare Institutions in Spain, 2007 18
Table 4: Hospital Beds by Type in Spain, 2007 18
Table 5: Number of Healthcare Personnel in Spain, 2007 19
Table 6: Number of Selected Medical Equipment in Spain, 2007 19
Table 7: Diabetes Care Devices, Spain, Overall Revenue ($m), Historic, 2000-2008 36
Table 8: Diabetes Care Devices, Spain, Overall Revenue ($m), Forecast, 2008-2015 38
Table 9: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2000-2008 40
Table 10: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2008-2015 42
Table 11: Diabetes Care Devices, Spain, Cross-Category Analysis, 2000-2015 43
Table 12: Diabetes Care Devices, Spain, Company Share by Revenue ($m), 2007-2008 44
Table 13: Glucose Monitoring, Spain, Revenue ($m) by Segment, Historic, 2000-2008 45
Table 14: Glucose Monitoring, Spain, Revenue ($m) by Segment, Forecast, 2008-2015 47
Table 15: Blood Glucose Meters, Spain, Revenue ($m) by Sub-Segment, Historic, 2000-2008 48
Table 16: Blood Glucose Meters, Spain, Revenue ($m) by Sub-Segment, Forecast, 2008-2015 49
Table 17: Glucose Monitoring, Spain, Volume (Units) by Segment, Historic, 2000-2008 50
Table 18: Glucose Monitoring, Spain, Volume (Units) by Segment, Forecast, 2008-2015 51
Table 19: Blood Glucose Meters, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008 52
Table 20: Blood Glucose Meters, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 52
Table 21: Glucose Monitoring, Spain, Cross-Segment Analysis, 2000-2015 53
Table 22: Glucose Monitoring, Spain, Average Price ($), Historic, 2000-2008 54
Table 23: Glucose Monitoring, Spain, Average Price ($), Forecast, 2008-2015 54
Table 24: Glucose Monitoring, Spain, Distribution Share by Revenue ($m), 2007-2008 56
Table 25: Glucose Monitoring, Spain, Company Share by Revenue ($m), 2007-2008 57
Table 26: Insulin Delivery, Spain, Revenue ($m) by Segment, Historic, 2000-2008 58
Table 27: Insulin Delivery, Spain, Revenue ($m) by Segment, Forecast, 2008-2015 60
Table 28: Insulin Pens, Spain, Revenue ($m) by Sub-Segment, Historic, 2000-2008 62
Table 29: Insulin Pens, Spain, Revenue ($m) by Sub-Segment, Forecast, 2008-2015 63
Table 30: Insulin Delivery, Spain, Volume (Units) by Segment, Historic, 2000-2008 64
Table 31: Insulin Delivery, Spain, Volume (Units) by Segment, Forecast, 2008-2015 65
Table 32: Insulin Pens, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008 66
Table 33: Insulin Pens, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 67
Table 34: Insulin Delivery, Spain, Cross-Segment Analysis, 2000-2015 68
Table 35: Insulin Delivery, Spain, Average Price ($), Historic, 2000-2008 69
Table 36: Insulin Delivery, Spain, Average Price ($), Forecast, 2008-2015 69
Table 37: Insulin Delivery, Spain, Distribution Share by Revenue ($m), 2007-2008 71
Table 38: Insulin Delivery, Spain, Company Share by Revenue ($m), 2007-2008 72
Table 39: F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 76
Table 40: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 76
Table 41: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 76
Table 42: LifeScan, Inc. Pipeline Products by Equipment Type 77
Table 43: LifeScan, Inc. Pipeline Products by Development Stage 77
Table 44: LifeScan, Inc. Pipeline Products by Therapy Area 77
Table 45: LifeScan, Inc. Pipeline Products by Clinical Trials 78
Table 46: LifeScan, Inc. Pipeline Products by News Summary 78
Table 47: Bayer HealthCare AG Pipeline Products by Equipment Type 81
Table 48: Bayer HealthCare AG Pipeline Products by Development Stage 82
Table 49: Bayer HealthCare AG Pipeline Products by Therapy Area 82
Table 50: Bayer HealthCare AG Pipeline Products by News Summary 82
Table 51: Abbott Laboratories Pipeline Products by Equipment Type 85
Table 52: Abbott Laboratories Pipeline Products by Development Stage 86
Table 53: Abbott Laboratories Pipeline Products by Therapy Area 86
Table 54: Abbott Laboratories Pipeline Products by Clinical Trials 87
Table 55: Abbott Laboratories Pipeline Products by News Summary 87
Table 56: Novo Nordisk A/S Pipeline Products by Equipment Type 90
Table 57: Novo Nordisk A/S Pipeline Products By Development Stage 90
Table 58: Novo Nordisk A/S Pipeline Products By Therapy Area 91
Table 59: Novo Nordisk A/S Pipeline Products By Clinical Trials 91
Table 60: Eli Lilly and Company Pipeline Products by Equipment Type 94
Table 61: Eli Lilly and Company Pipeline Products by Development Stage 95
Table 62: Eli Lilly and Company Pipeline Products by Therapy Area 95
Table 63: Eli Lilly and Company Pipeline Products by Clinical Trials 95
Table 64: Eli Lilly and Company Pipeline Products by News Summary 95
Table 65: Medtronic, Inc. Pipeline Products by Equipment Type 99
Table 66: Medtronic, Inc. Pipeline Products By Development Stage 101
Table 67: Medtronic, Inc. Pipeline Products By Therapy Area 103
Table 68: Medtronic, Inc. Pipeline Products By Clinical Trials 105
Table 69: Medtronic, Inc. Pipeline Products By News Summary 106
Table 70: ARKRAY, Inc. Pipeline Products by Equipment Type 107
Table 71: ARKRAY, Inc. Pipeline Products by Development Stage 107
Table 72: ARKRAY, Inc. Pipeline Products by Clinical Trials 108
Table 73: ARKRAY, Inc. Pipeline Products by News Summary 108
Table 74: USD to Local Currency, Average Exchange Rate 2008 119

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in Spain, 2000 – 2006 15
Figure 2: Flowchart for Classification of Non-invasive Devices in Spain, 2007 22
Figure 3: Flowchart for Classification of Invasive Devices in Spain, 2007 23
Figure 4: Flowchart for Classification of Invasive Devices in Spain, 2007 24
Figure 5: Flowchart for Classification of Invasive Devices in Spain, 2007 25
Figure 6: Flowchart for Classification of Invasive Devices in Spain, 2007 26
Figure 7: Flowchart for Classification of Active Devices in Spain, 2007 27
Figure 8: Flowchart for Classification of Active Devices in Spain, 2007 28
Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Spain, 2007 29
Figure 10: Conformity Assessment of Class-I Medical Devices in Spain, 2007 30
Figure 11: Conformity Assessment of Class-IIa Medical Devices in Spain, 2007 31
Figure 12: Conformity Assessment of Class-IIb Medical Devices in Spain, 2007 32
Figure 13: Conformity Assessment of Class-III Medical Devices in Spain, 2007 33
Figure 14: Diabetes Care Devices, Spain, Overall Revenue ($m), Historic, 2000-2008 36
Figure 15: Diabetes Care Devices, Spain, Overall Revenue ($m), Forecast, 2008-2015 38
Figure 16: Diabetes Care Devices, Spain, Category Volume (Units), Historic, 2000-2008 40
Figure 17: Diabetes Care Devices, Spain, Category Volume (Units), Forecast, 2008-2015 42
Figure 18: Diabetes Care Devices, Spain, Cross-Category Analysis, 2000-2015 43
Figure 19: Diabetes Care Devices, Spain, Company Share (%), 2008 44
Figure 20: Glucose Monitoring, Spain, Revenue ($m) by Segment, Historic, 2000-2008 45
Figure 21: Glucose Monitoring, Spain, Revenue ($m) by Segment, Forecast, 2008-2015 47
Figure 22: Blood Glucose Meters, Spain, Revenue ($m) by Sub-Segment, Historic, 2000-2008 48
Figure 23: Blood Glucose Meters, Spain, Revenue ($m) by Sub-Segment, Forecast, 2008-2015 49
Figure 24: Glucose Monitoring, Spain, Volume (Units) by Segment, Historic, 2000-2008 50
Figure 25: Glucose Monitoring, Spain, Volume (Units) by Segment, Forecast, 2008-2015 51
Figure 26: Glucose Monitoring, Spain, Cross-Segment Analysis, 2000-2015 53
Figure 27: Glucose Monitoring, Spain, Company Share (%), 2008 57
Figure 28: Insulin Delivery, Spain, Revenue ($m) by Segment, Historic, 2000-2008 58
Figure 29: Insulin Delivery, Spain, Revenue ($m) by Segment, Forecast, 2008-2015 60
Figure 30: Insulin Pens, Spain, Revenue ($m) by Sub-Segment, Historic, 2000-2008 62
Figure 31: Insulin Pens, Spain, Revenue ($m) by Sub-Segment, Forecast, 2008-2015 63
Figure 32: Insulin Pens, Spain, Volume (Units) by Sub-Segment, Historic, 2000-2008 66
Figure 33: Insulin Pens, Spain, Volume (Units) by Sub-Segment, Forecast, 2008-2015 67
Figure 34: Insulin Delivery, Spain, Cross-Segment Analysis, 2000-2015 68
Figure 35: Insulin Delivery, Spain, Company Share (%), 2008 72
Figure 36: GlobalData Methodology 115